Buy Glaxo Smithkline Pharma for target of Rs 2160: APTART

MUMBAI: Sandeep Wagle, MD, APTART is of the view that Glaxo Smithkline Pharma has seen a price and volume breakout. He has advised traders to buy the stock for target of Rs 2160.

“Buy Glaxo Smithkline Pharma in the range of Rs 2070-2050 with stoploss of Rs 2035 for target of Rs 2160. Price and volume breakout seen in the stock,” said Wagle.

Note: Trading idea valid for time-period of 7-8 trading sessions.

The entry / exit price levels, stop-losses, targets as well as the time frames are indicative and viewers should use their discretion in implementing the same.